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ABSTRAK (BAHASA MELAYU) 
 
Pengenalan: Rhinosinusitis kronik (CRS) adalah merupakan salah satu penyakit keradangan 
yang seringkali berlaku dan kompleks, yang melibatkan mukosa hidung dan paranasal sinus. 
Walaupun patogenesis CRS adalah multifaktorial dan masih tidak jelas, peranan sitokin 
terutamanya interleukin-1 (IL-1) sedang diselidiki di seluruh dunia dalam populasi yang 
berbeza kerana keputusan yang berbeza-beza diperolehi. 
 
Objektif: Untuk mengkaji hubungan antara polimorfisme genetik IL-1 (A dan B) dengan 
rhinosinusitis kronik dengan polip hidung (CRSwNP) dan tanpa polip hidung (CRSsNP), dan 
faktor lain yang berkaitan. 
 
Kaedah: Ini adalah kajian terkawal yang melibatkan sejumlah 138 subjek yang direkrut dari 
klinik Otorinolaringologi- Pembedahan Kepala dan Leher (ORL-HNS) di Hospital Universiti 
Sains Malaysia (HUSM). Genotyping IL-1A (+4845G, +4845T) dan IL-1B (-511C, -511T) 
dilakukan dengan analisa panjang pecahan polimorfisme (RFLP). 
 
Keputusan: Dari 138 peserta, terdapat 61 lelaki (44.2%) dan 77 (55.8%) wanita. Umur 
purata [SD] pada diagnosis adalah 46.6 [13.70] dan 34.41 [12.37] tahun bagi CRSwNP dan 
CRSsNP, masing-masing. Majoriti subjek adalah asal Melayu. Sejarah merokok dikaitkan 
dengan pesakit CRSwNP dan CRSsNP (p-value <0.001). Terdapat hubungan penting statistik 
antara IL-1B (-511C, -511T) polimorfisme dengan CRSwNP dan CRSsNP (p-value <0.001). 
Genotip CT dalam IL-1 B adalah tinggi dengan ketara dalam subjek CRSwNP. 
Walaubagaimanapun, tiada hubungan yang signifikan antara IL-1A (+4845G, +4845T) dan 
CRSwNP dan CRSsNP (p-value = 0.093). Tiada hubungan yang penting dijumpai dalam 
	   vi	  
faktor-faktor yang berkaitan dengan CRS, termasuk asma, atopy, alergi, sensitiviti kepada  
aspirin dan sejarah keluarga polip hidung (p-value 0.382, 0.382, 0.144, >0.95 dan 0.254 
masing-masing). 
 
Kesimpulan: Kajian ini menunjukkan terdapat hubungan antara IL-1B (-511C, -511T)  
polimorfisme dengan CRSwNP dan CRSsNP dalam populasi kita, oleh itu terdapat 
kemungkinan penglibatan IL-1B dalam memodulasi patogenesis CRS. Tiada hubungan 
signifikan IL-1A (+4845G, +4845T) polimorfisme dengan CRSwNP dan CRSsNP, dan faktor 
lain yang berkaitan. 
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ABSTRACT (ENGLIGH) 
 
Background: Chronic rhinosinusitis (CRS) is one of the most common and complex chronic 
inflammatory disease of sinonasal mucosa. Eventhough the pathogenesis of CRS is 
multifactorial and still unclear, the role of cytokines especially interleukin-1 (IL-1) is being 
investigated worldwide in different population because of varying results obtained.   
 
Objective: To study the association of IL-1 (A and B) gene polymorphisms with chronic 
rhinosinusitis with nasal polyp (CRSwNP) and without NP (CRSsNP), and other factors 
related.   
 
Methods: This is a case controlled study which include a total of 138 subjects recruited from 
Otorhinolaryngology-Head and Neck Surgery (ORL-HNS) clinic in Hospital Universiti Sains 
Malaysia (HUSM). Genotyping of the IL-1A (+4845G, +4845T) and IL-1B (-511C, -511T) 
was performed with restriction fragment length polymorphism (RFLP) analysis. 
 
Results: From 138 participants, there were 61 males (44.2%) and 77 (55.8%) females. The 
mean [SD] age at diagnosis was 46.6 [13.70] and 34.41 [12.37] years for CRSwNP and 
CRSsNP, respectively. Majority of the subjects was Malay in origin. Cigarette smoking was 
significantly associated with CRSwNP and CRSsNP patients (p-value < 0.001). There was a 
statistical significant association between IL-1B (-511C, -511T) gene polymorphism with 
CRSwNP and CRSsNP (p-value < 0.001). The CT genotype of IL-1B was markedly 
increased in CRSwNP subjects. However, there was no significant association found between 
IL-1A (+4845G, +4845T) and CRSwNP and CRSsNP (p-value = 0.093). No association was 
found in factors related to CRS, which included asthma, atopy, allergy, aspirin sensitivity and 
	   viii	  
family history of nasal polyp (NP) (p-value of 0.382, 0.382, 0.144, >0.95 and 0.254, 
respectively). 
 
Conclusion: This study indicates an association of IL-1B (-511C, -511T) polymorphism with 
CRSwNP and CRSsNP in our population, hence there is a possibility of IL-1B involvement in 
modulating pathogenesis of CRS. There was no significant association of IL-1A (+4845G, 






















	   2	  
CHAPTER 1: INTRODUCTION  
 
Chronic rhinosinusitis (CRS) is one of the most common chronic inflammatory disease of 
sinonasal mucosa, affecting 15.5% of the total population in United States (US), making it 
the second most common condition of all chronic conditions [1]. The Global Allergy and 
Asthma Network of Excellence (GA2LEN) study revealed that the overall prevalance  of CRS 
in the Europe countries was 10.9% [2], whereas the prevalence in the Asian countries was 
reported to be around 6.9% to 8.0% [3].  
 
CRS can be further classified into two phenotypes: CRS with nasal polyps (CRSwNP) and 
CRS without nasal polyps (CRSsNP) [4]. Histopathologically, nasal polyp is categorized by 
proliferation of the epithelial layer, thickening of the basement membrane, focal fibrosis, 
glandular hyperplasia, oedema, cellular infiltration of stromal layer and presence of 
inflammatory cells [5-6]. It is usually bilateral and described as peeled grape-like, glistening, 
pale-grey, smooth, semitransparent mass with a pedicle arising from the osteomeatal-
complex [7-8]. Apart from the presence of polyp in the nasal cavity for CRSwNP, these 
patients were reported to have a higher frequency of nasal discharge, nasal obstruction and 
change in smell, as compared to CRSsNP patients who complain more of facial pain or 
headache [9]. 
 
CRS is a complex disease whereby the actual pathogenesis is still under active investigation 
and is believed to be of a multifactorial. The inflammatory reaction of the sinonasal mucosal 
lining causing mucosal oedema which obstructs the sinus ostia, leading to mucus retention 
and infection, hence development of CRS [10]. Among the predisposing factors associated 
with this disease are asthma, aspirin sensitivity, allergy, atopy, cigarette smoking and genetic 
	   3	  
factor [1]. It is also believed that CRS is affected by multiple genes that may interact with 
undetermined environmental factors and potentially cause disease expression [1]. 
 
Interleukin-1 (IL-1) is one of the most important proinflammatory cytokines as well as a 
potent transmitter between cells which modulates early in the cascade of inflammatory 
response in CRSwNP [11]. IL-1 plays a role in activating T lymphocytes and monocytes, and 
also upregulating expression of  adhesion molecules such as intercellular adhesion molecule-
1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) [6, 12]. IL-1 exists in three 
forms namely IL-1A, IL-1B and IL-1 receptor antagonist (IL-1 Ra), which are located on the 
long arm of chromosome 2 [6].  
 
Several studies conducted in different countries had proven that genetic polymorphisms of 
IL-1 have been contributed to  development of CRS. Genetic polymorphism is defined as 
multiple alleles occur at a single locus, whereby at least two alleles present with a frequency 
greater than 1 percent [13]. Initially, Karjalainen et al. [14] demonstrated an association of  
IL-1A (+4845G, +4845T) with nasal polyp in asthmatic adults in Finnish population. Similar 
finding was subsequently found in CRS patients in Canadian population [6]. A Turkish study 
successfully reported association of both IL-1A (+4845G, +4845T) and IL-1B (-511C, -511T) 
polymorphisms with CRSwNP patients [5]. In contrast, Bernstein et al. [15] in United State 
of America (USA) showed no significant association of IL-1A and IL-1B in their CRSwNP 
patients. The contradictory results may suggest that variation between ethnic groups affecting 
frequency of many genetic alleles [16].  
 
Besides CRS, studies shown that IL-1 genetic polymorphisms is also associated with other 
inflammatory disease such as periodontitis,  rheumatoid athritis, inflammatory bowel disease 
	   4	  
and gout [16-19]. Examples of IL-1 inhibitor available in clinical use are anakinra, 
canakinumab and rilonacept which are effective in the advanced treatment of gout [19]. 
 
To date, there is no such study done in Southeast population, the present study aimed to study 
the association of IL-1A and IL-1B genetic polymorphisms with CRSwNP and CRSsNP. 
Besides that, we also attempted to determine the association of other factors (asthma, atopy, 
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CHAPTER 2: OBJECTIVES OF THE STUDY 
 
2.1 GENERAL OBJECTIVE 
 
The general objective for this study was to determine the association of Interleukin-1 (IL-1) 
gene polymorphisms with chronic rhinosinusitis (CRS) with (CRSwNP) and without nasal 
polyp (CRSsNP). 
 
2.2 SPECIFIC OBJECTIVES 
 
The specific objectives for this study were as the following: 
 
i) To profile the CRS patient population in Hospital Universiti Sains Malaysia 
(HUSM). 
 
ii) To determine the association of IL-1A and IL-1B gene polymorphisms with 
CRSwNP, CRSsNP and control. 
 
iii) To determine the association of other factors (asthma, atopy, allergy, aspirin 
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ABSTRACT 22	  
 23	  
Background: Chronic rhinosinusitis (CRS) is one of the most common and complex chronic 24	  
inflammatory disease of sinonasal mucosa. Eventhough the pathogenesis of CRS is 25	  
multifactorial and still unclear, the role of cytokines especially interleukin-1 (IL-1) is being 26	  
investigated worldwide in different population because of varying results obtained.   27	  
Objective: To study the association of IL-1 (A and B) gene polymorphisms with chronic 28	  
rhinosinusitis with nasal polyp (CRSwNP) and without NP (CRSsNP), and other factors 29	  
related.   30	  
Methods: This is a case controlled study which include a total of 138 subjects recruited from 31	  
Otorhinolaryngology-Head and Neck Surgery (ORL-HNS) clinic in Hospital Universiti Sains 32	  
Malaysia (HUSM). Genotyping of the IL-1A (+4845G, +4845T) and IL-1B (-511C, -511T) 33	  
were performed with restriction fragment length polymorphism (RFLP) analysis. 34	  
Results: There was a statistical significant association between IL-1B (-511C, -511T)  35	  
polymorphism with CRSwNP and CRSsNP (p-value <0.001). The CT genotype of IL-1B was 36	  
markedly increased in CRSwNP subjects (52.2%). However, there was no significant 37	  
association found between IL-1A (+4845G, +4845T) with CRSwNP and CRSsNP (p-value = 38	  
0.093). No association was found in factors related to CRS, which included asthma, atopy, 39	  
allergy, aspirin sensitivity and family history of nasal polyp (NP) (p-value of 0.382, 0.382, 40	  
0.144, >0.95 and 0.254, respectively). 41	  
Conclusion: This study indicates an association of IL-1B (-511C, -511T)  polymorphism 42	  
with CRSwNP and CRSsNP in our population, hence there is a possibility of IL-1B 43	  
involvement in modulating pathogenesis of CRS. There was no significant association of IL-44	  
1A (+4845G, +4845T) polymorphism with CRSwNP and CRSsNP, and other factors related.   45	  
 46	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INTRODUCTION 72	  
 73	  
Chronic rhinosinusitis (CRS) is one of the most common chronic inflammatory disease of 74	  
sinonasal mucosa, affecting 15.5% of the total population in United States (US), making it 75	  
the second most common condition of all chronic conditions [1]. The Global Allergy and 76	  
Asthma Network of Excellence (GA2LEN) study revealed that the overall prevalance  of CRS 77	  
in the Europe countries was 10.9% [2], whereas the prevalence in the Asian countries was 78	  
reported to be around 6.9% to 8.0% [3].  79	  
 80	  
CRS can be further classified into two phenotypes: CRS with nasal polyps (CRSwNP) and 81	  
CRS without nasal polyps (CRSsNP) [4]. Histopathologically, nasal polyp is categorized by 82	  
proliferation of the epithelial layer, thickening of the basement membrane, focal fibrosis, 83	  
glandular hyperplasia, oedema, cellular infiltration of stromal layer and presence of 84	  
inflammatory cells [5-6]. It is usually bilateral and described as peeled grape-like, glistening, 85	  
pale-grey, smooth, semitransparent mass with a pedicle arising from the osteomeatal-86	  
complex [7-8]. Apart from the presence of polyp in the nasal cavity for CRSwNP, these 87	  
patients were reported to have a higher frequency of nasal discharge, nasal obstruction and 88	  
change in smell, as compared to CRSsNP patients who complain more of facial pain or 89	  
headache [9]. 90	  
 91	  
CRS is a complex disease whereby the actual pathogenesis is still under active investigation 92	  
and is believed to be of a multifactorial. The inflammatory reaction of the sinonasal mucosal 93	  
lining causing mucosal oedema which obstructs the sinus ostia, leading to mucus retention 94	  
and infection, hence development of CRS [10]. Among the predisposing factors associated 95	  
with this disease are asthma, aspirin sensitivity, allergy, atopy, cigarette smoking and genetic 96	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factor [1]. It is also believed that CRS is affected by multiple genes that may interact with 97	  
undetermined environmental factors and potentially cause disease expression [1]. 98	  
 99	  
Interleukin-1 (IL-1) is one of the most important proinflammatory cytokines as well as a 100	  
potent transmitter between cells which modulates early in the cascade of inflammatory 101	  
response in CRSwNP [11]. IL-1 plays a role in activating T lymphocytes and monocytes, and 102	  
also upregulating expression of  adhesion molecules such as intercellular adhesion molecule-103	  
1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) [6, 12]. IL-1 exists in three 104	  
forms namely IL-1A, IL-1B and IL-1 receptor antagonist (IL-1 Ra), which are located on the 105	  
long arm of chromosome 2 [6].  106	  
 107	  
Several studies conducted in different countries had proven that genetic polymorphisms of 108	  
IL-1 have been contributed to  development of CRS. Genetic polymorphism is defined as 109	  
multiple alleles occur at a single locus, whereby at least two alleles present with a frequency 110	  
greater than 1 percent [13]. Initially, Karjalainen et al. [14] demonstrated an association of  111	  
IL-1A (+4845G, +4845T) with nasal polyp in asthmatic adults in Finnish population. Similar 112	  
finding was subsequently found in CRS patients in Canadian population [6]. A Turkish study 113	  
successfully reported association of both IL-1A (+4845G, +4845T) and IL-1B (-511C, -511T) 114	  
polymorphisms with CRSwNP patients [5]. In contrast, Bernstein et al. [15] in United State 115	  
of America (USA) showed no significant association of IL-1A and IL-1B in their CRSwNP 116	  
patients. The contradictory results may suggest that variation between ethnic groups affecting 117	  
frequency of many genetic alleles [16].  118	  
 119	  
Besides CRS, studies shown that IL-1 genetic polymorphisms is also associated with other 120	  
inflammatory disease such as periodontitis,  rheumatoid athritis, inflammatory bowel disease 121	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and gout [16-19]. Examples of IL-1 inhibitor available in clinical use are anakinra, 122	  
canakinumab and rilonacept which are effective in the advanced treatment of gout [19]. 123	  
 124	  
To date, there is no such study done in Southeast population, the present study aimed to study 125	  
the association of IL-1A and IL-1B genetic polymorphisms with CRSwNP and CRSsNP. 126	  
Besides that, we also attempted to determine the association of other factors (asthma, atopy, 127	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MATERIAL AND METHODS 147	  
 148	  
Sample size calculation 149	  
Sample size calculation was determined by using Power and Sample software (Version 150	  
3.0.43) based on previous literature by Karjalainen et al. [14] and Berstein et al. [15]. The 151	  
power of study used was 0.80 with level of statistical significant (α) of 0.05, meanwhile the 152	  
probablitity of exposure among controls and cases were 0.40 and 0.70. 10% drop out was 153	  
added to the largest sample size calculated making it 138 subjects in total (46 subjects in each 154	  
group: CRSwNP, CRSsNP and control). 155	  
 156	  
Subjects 157	  
A case controlled study was conducted with a total of 92 patients (46 CRSwNP patients and 158	  
46 CRSsNP patients) and 46 controls aged more than 18 years old were recruited from 159	  
Otorhinolaryngology-Head and Neck Surgery (ORL-HNS) clinic in Hospital Universiti Sains 160	  
Malaysia (HUSM). The diagnosis of CRS was based on clinical history and confirmed by 161	  
direct visualisation via nasal endoscopy as proposed by the European Position Paper on 162	  
Rhinosinusitis and Nasal Polyp (EPOS) [1] or those with history of polypectomy confirmed 163	  
with pathology reports. Those with cystic fibrosis, Kartagener’s syndrome, Young syndrome, 164	  
antrochoanal polyp, inverted papilloma or any malignancy were excluded from the cases. The 165	  
control group consisted of healthy individuals those who volunteered. They were not blood-166	  
related to the cases and living in the same district areas with the cases to minimise the 167	  
environmental bias. They did not have any history of nasal symptoms, allergy, family history 168	  
of allergy and any chronic inflammatory disorders. 169	  
 170	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A standardised questionnaire comprised of demographic characteristics (e.g. age at diagnosis, 171	  
gender, ethnicity, and smoking history), duration of symptoms, nasal symptoms (according to 172	  
EPOS 2012) [1], history of previous sinus surgery, predisposing factors of CRS (e.g. the 173	  
presence of asthma, atopy, allergy, aspirin intolerance, and family history of nasal polyps) 174	  
and nasoendoscopic findings were  obtained from all subjects. During nasoendoscopy, 175	  
presence of any polyp, grading of nasal polyp (according to Lund [20]), mucopurulent 176	  
discharge or obstruction in the middle meatus, and mucosal oedema were recorded.  177	  
  178	  
Deoxyribonucleic acid (DNA) collection and extraction 179	  
Each patient’s DNA was collected using a buccal swab and then stored at -20 degree celcius 180	  
until DNA extraction was done. Then, the DNA extraction was performed using ExgeneTM 181	  
Blood SV Mini Kit (GeneAll®, Korea) by following the manufacturer’s protocol. 182	  
 183	  
Polymerase chain reaction (PCR) and restriction fragment length polymorphism 184	  
(RFLP)  185	  
The genotype of IL-1A (+4845G, +4845T) and IL-1B (-511C, -511T) were determined by 186	  
PCR amplification by using Master Cycler Vapo Protect (Eppendorf, Germany) with the 187	  
primers as identified by Karjalainen et al. [14], then followed by RFLP. The primers used for 188	  
IL1A and IL1B were as following: 5’-ATG GTT TTA GAA ATC ATC AAG CCT AGG 189	  
GCA-3’ (forward primer) and 5’-AAT GAA AGG AGG GGA GGA TGA CAG AAA TGT-190	  
3’ (reverse primer); and 5’-TGGCATTGATCTGGTTCATC-3’ (forward primer) and 5’-191	  
GTTTAGGAATCTTCCCACTT-3’ (reverse primer), respectively. Then, for both genes, 1 192	  
μL forward primer, 1 μL reverse primer, 3 μL genomic DNA, 5 μL Dnase free water and 10 193	  
μL Phusion® High-Fidelity PCR Master Mix with HF Buffer (New England Biolabs, USA) 194	  
were mixed together. The PCR cycling conditions were as follows: (a) For IL-1A (+4845G, 195	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+4845T) initial denaturation at 94 °C for 3 minutes (min), 30 cycles of denaturation at 98 °C 196	  
for for 60 seconds (s), annealing at 54 °C for 60 s, extension at 72 °C for 2 min and final 197	  
extension at 72 °C at 5 min; (b) For IL-1B (-511C, -511T): initial denaturation at 94 °C for 10 198	  
min, 30 cycles of denaturation at 94 °C for for 45 s, annealing at 55 °C for 45 s, extension at 199	  
72 °C for 60 s and final extension at 72 °C at 10 min.  200	  
   201	  
Subsequently, to detect IL-1A (+4845G, +4845T), digestion with restriction enzyme SatI 202	  
(New England Biolabs®, UK) was performed after amplification to yield 124-,76-, and 29-203	  
base pair (bp) bands in the presence of allele G, and 153-bp and 76-bp bands in the presence 204	  
of allele T [5].  Whilst, to detect IL-1B (-511C, -511T), digestion with restriction enzyme 205	  
AvaI (New England Biolabs®, UK) is performed to yield 305-bp bands in the presence of 206	  
allele C, and 190-bp and 115-bp bands in the presence of allele T [5]. Therefore, a 4.0 µL 207	  
PCR product were digested with 0.5 µL respective restriction enzyme together with 18.0 µL 208	  
Dnase free water and 2.5 µL CutSmart® buffer. Then, the mixture was spun down for a few 209	  
seconds and incubated at 37 °C for 20 minutes. The PCR product was also sent for DNA 210	  
sequencing for validation. 211	  
 212	  
Electrophoresis  213	  
The 10-12 µL digested DNA was added with 1-2 µL BlueJuice Gel Loading buffer 214	  
(Invitrogen, USA) and loaded into the 2.5% Agarose gel for IL-1A and 2% Agarose gel for 215	  
IL-1B. Following that, the digested DNA was separated on the Agarose gel and stained with 216	  
SYBR® Safe DNA gel stain at 75 volts (V) for 90 min and 70 V for 60 min for IL-1A and IL-217	  
1B, respectively. The image on the Agarose gel was then visualised under ultraviolet light 218	  
and captured using an image analyser i.e. Quantity One, 1-D Analysis Software (Bio-Rad 219	  
Laboratories, USA). 220	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Statistical analysis 221	  
The statistical calculation and evaluation were performed with IBM SPSS version 22.0 (IBM, 222	  
Armonk, NY, USA). The data analysis was derived descriptively and the inferential statistics 223	  
mainly used Pearson chi square test, Fisher-Exact test and simple logistic regression. A p 224	  
value of less than  0.05 is considered significant.  225	  
 226	  
Ethical approval 227	  
The study protocol was approved by Human Research Ethics Committee of Universiti Sains 228	  
Malaysia (Federalwide Assurance Registration No. 00007718; Instituitional Review Board 229	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RESULTS 246	  
 247	  
From 138 participants, there were 61 males (44.2%) and 77 (55.8%) females. The mean [SD] 248	  
age at diagnosis was 46.6 [13.70] and 34.41 [12.37] years for CRSwNP and CRSsNP, 249	  
respectively. Meanwhile, the mean [SD] age for cases and control was 40.52 [14.36] and 250	  
42.41 [12.26] years. Majority of the subjects was Malay in origin followed by Chinese, 251	  
Indian and others. Cigarette smoking was significantly associated with CRSwNP and 252	  
CRSsNP patient (p-value < 0.001).  253	  
 254	  
The SNPs for IL-1A (+4845G, +4845T) and IL-1B (-511C, -511T) were successfully 255	  
genotyped. For IL-1A (+4845G, +4845T), homozygous wild-type (GG) expected to produce 256	  
three fragments of 124 bp, 76 bp and 29 bp. However, the 29 bp was too small to be captured 257	  
in the 2.5% Agarose gel electrophoresis. Homozygous mutant-type (TT) produced two 258	  
fragments of 153 bp and 76 bp, and therefore, heterozygous mutant-type (GT) was seen to 259	  
yield 153 bp, 124 bp, 76 bp and 29 bp fragments as shown in Fig. 1. On the other hand, the 260	  
uncut fragment of 305 bp represented the homozygous wild-type (CC) for IL-1B (-511C, -261	  
511T). Heterozygous mutant-type (CT) yielded three fragments of 305 bp, 190 bp and 115 262	  
bp, and homozygous mutant-type (TT) produced two fragments of 190 bp and 115 bp as 263	  
shown in Fig. 2. 264	  
 265	  
Table 1 illustrates the genotype distributions and allele frequencies of both IL-1A and IL-1B  266	  
in CRSwNP, CRSsNP and controls. The GT genotype of IL-1A was common in patients with 267	  
CRSwNP and CRSsNP but not amongst controls. Whereas, TT was a common genotype in 268	  
controls. Thus, these findings contributed to  significantly higher frequency of T allele (p-269	  
value = 0.021). However, there was no statistical significant  270	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differences found between IL-1A (+4845G, +4845T) genotype distributions against 271	  
CRSwNP, CRSsNP and controls (p-value = 0.093).  272	  
 273	  
Indeed, our study showed a significant association of IL-1B (-511C, -511T) polymorphism 274	  
with both CRSwNP and CRSsNP patients (p-value <0.001). A slightly different trend of 275	  
genotype frequencies was observed in IL-1B (-511C, -511T) polymorphism. The frequency 276	  
of CC genotype of IL-1B was significantly higher in CRSsNP and controls (p-value <0.001). 277	  
However, in patients with CRSwNP, CT genotype was markedly increased in IL-1B. In terms 278	  
of allele frequency, allele T was found to be highly associated with CRSwNP compared to 279	  
CRSsNP and control groups (p-value <0.001).  280	  
 281	  
No significant association was found in all factors related to CRS, which includes asthma, 282	  
atopy, allergy, aspirin sensitivity and family history of NP with respective p-values (all p-283	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DISCUSSION 296	  
 297	  
This study demonstrated that there was a statistically significant association between IL-1B (-298	  
511C, -511T) polymorphism with both CRSwNP and CRSsNP patients (p-value <0.001) 299	  
which is consistent with a study by Erbek et al. [5] in a Turkish population. This proves that 300	  
single nucleotide polymorphism (SNP) of IL-1B within the promoter region at locus -511 in 301	  
chromosome 2 maybe one of the key players in the inflammatory cascade of CRSwNP as 302	  
well as CRSsNP. However, the means by which this gene results in the clinical progression 303	  
of the disease is unknown. The IL-1B (-511C, -511T) polymorphism may affect or alter the 304	  
transcription of other cytokine genes involved in the disease process [21]. Perhaps further 305	  
studies of this gene can be conducted in an even larger sample size to reduce the risk of 306	  
random association between SNPs and CRS patients. 307	  
 308	  
Our finding of CT genotype of IL-1B as a significantly common genotype (p-value <0.01) in 309	  
CRSwNP population is also similar to other studies [5, 12, 14]. However, studies by Cheng et 310	  
al. [5] and Erbek et al. [12] showed that CT genotype as a common genotype in CRSsNP 311	  
population. This may imply that CT genotype of IL-1B gene is an important genotype for 312	  
development of both CRSwNP and CRSsNP in Asian population. In contrary, other studies 313	  
[12, 15] also investigated the association of genetic polymorphism of IL-1B at position -511 314	  
and at different polymorphism site such as at exon 5 for IL-1B (+3953C, +3953T). However, 315	  
no statistical difference were found between those genes and subjects tested. Table 3 showed 316	  
various studies performed investigating IL-1A and IL-1B polymorphism with nasal polyposis 317	  
in different populations. 318	  
 319	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Even though our study did not find any association between IL-1A (+4845G, +4845T) 320	  
genotype distributions against CRS patients and controls (p-value = 0.093), but the role of IL-321	  
1A gene family still cannot be ruled out as other studies [5-6, 14] had shown significant 322	  
association as been summarised in Table 3. This leads to a possibility that variation exists 323	  
between the ethnicity affecting frequency of many genetic alleles [16]. Besides that, this lack 324	  
of association between IL-1A (+4845G, +4845T) gene polymorphism and CRSwNP or 325	  
CRSsNP, maybe contributed by epigenetic factors such as environmental factor interacting 326	  
within the genome and immunologic process modified by immunomodulator prescribed to 327	  
the patient [10, 21]. For example, macrolides used in treatment of CRSwNP, may inhibit 328	  
neutrophilic rather than eosinophilic activity and macrophage activation, and lower the IL-1B 329	  
concentration [22]. 330	  
 331	  
No significant association found in this study for the factors related to CRSwNP and 332	  
CRSsNP patients with regards to asthma, atopy, allergy, aspirin sensitivity and family history 333	  
of nasal polyp (all p-values > 0.05). However, our demographic data revealed that there was 334	  
an association of environmental factor such as smoking history with CRS patients (p-value = 335	  
0.017) which is consistent with other studies [2, 23]. 336	  
 337	  
There was a well-established association between aspirin sensitivity, asthma and CRSwNP 338	  
termed “aspirin-exacerbated respiratory disease” (AERD) or Samter’s triad [24-25]. Failure 339	  
in obtaining association with aspirin sensitivity in the present study could be due to the low 340	  
number of patients (only two patients out of total 138 subjects) who had consumed aspirin. 341	  
This low incidence maybe due to an underestimation of aspirin sensitivity as the data was 342	  
again based on patient’s history and majority of our patients may have not taken aspirin 343	  
before. Aspirin is commonly used as a prophylaxis for cardiovascular diseases worldwide. It 344	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was underutilised in Asian countries compared to Western population maybe due to 345	  
overestimation of bleeding risks by the physicians [26].  346	  
 347	  
The relationship of CRSwNP and positive family history of nasal polyp has been well-348	  
established [1, 27-28]. Nevertheless, an identical twin study showed that both siblings did not 349	  
always develop nasal polyps and this discordance proposed the role of environmental factors 350	  
that may affect disease expression [1, 29]. The lack of association of family history of nasal 351	  
polyp and CRS in our study was obtained maybe contributed by underestimation of family 352	  
history of nasal polyp. Some of our patients claimed that their family member had not seek 353	  
any medical check-up as they were asymptomatic, thus assuming that their family member 354	  
does not have any nasal polyp.  355	  
 356	  
In terms of study limitation, the subjects were not homogenously distributed between the 357	  
subgroups. The subjects should be equally matched for age, gender and ethnicity to reduce 358	  
the bias by the confounders. We attempted to reduce the environmental bias by matching the 359	  
subjects geographically. In terms of sample size, the number of cases in our study (n = 92) is 360	  
comparable to other studies (a total number of 35-179 cases) [5, 12, 14-15]. This study might 361	  
not represent the general population in Malaysia because the distribution of ethnic groups in 362	  
Kelantan differs from other states of Malaysia. Therefore, a larger sample size and multi-363	  
centre study would be more representative of CRS population in Malaysia. 364	  
 365	  
In conclusion, this study indicates an association of IL-1B (-511C, -511T)  polymorphism 366	  
with CRSwNP and CRSsNP in our population, hence there is a possibility of IL-1B 367	  
involvement in modulating pathogenesis of CRS. Therefore, it can be a potential new target 368	  
for treatment of CRS. We hope that this finding added a significant value in contributing to 369	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understanding of genetics and pathogenesis of CRS in our population. Perhaps future 370	  
research can improvise this study to use IL-1B as a genetic marker for disease susceptibility 371	  
and risk stratification especially in patients with CRSwNP so that we can predict which 372	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